Please use this identifier to cite or link to this item:
https://ahro.austin.org.au/austinjspui/handle/1/33472| Title: | Obesity and 'functional hypogonadism' - mechanisms and management: Commentary on EJE-22-1110 "Leflutrozole in Male Obesity-Associated Hypogonadotropic Hypogonadism: Ph 2b Double-Blind RCT". | Austin Authors: | Inder, Warrick J;Grossmann, Mathis | Affiliation: | Department of Diabetes and Endocrinology, Princess Alexandra Hospital, Brisbane QLD, Australia.;Faculty of Medicine, The University of Queensland, Brisbane QLD, Australia. Medicine (University of Melbourne) Endocrinology |
Issue Date: | 1-Sep-2023 | Date: | 2023 | Publication information: | European Journal of Endocrinology 2023-09-01; 189(3) | URI: | https://ahro.austin.org.au/austinjspui/handle/1/33472 | DOI: | 10.1093/ejendo/lvad100 | ORCID: | 0000-0001-8261-3457 | Journal: | European Journal of Endocrinology | PubMed URL: | 37548170 | ISSN: | 1479-683X | Type: | Journal Article | Subjects: | SERM androgen aromatase inhibitor hypogonadism testosterone |
| Appears in Collections: | Journal articles |
Show full item record
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.